|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn994495531 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
110202s2011 nyua ob 001 0 eng |
010 |
|
|
|a 2020677793
|
040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d OCLCF
|d XFH
|d OCLCO
|d N$T
|d YDXCP
|d E7B
|d NLGGC
|d EBLCP
|d AZK
|d LOA
|d AGLDB
|d ICA
|d MOR
|d PIFAG
|d MERUC
|d ZCU
|d U3W
|d D6H
|d STF
|d WRM
|d VTS
|d NRAMU
|d ICG
|d VT2
|d AU@
|d WYU
|d DKC
|d M8D
|d UX1
|d UKCRE
|d AJS
|d OCLCO
|d OCLCQ
|
016 |
7 |
|
|a 015869554
|2 Uk
|
019 |
|
|
|a 829713428
|a 961655039
|a 962649340
|a 965991988
|a 988475899
|a 992090558
|a 1037904267
|a 1038624979
|a 1045477798
|a 1055404289
|a 1058076375
|a 1066644404
|a 1081272570
|a 1153511527
|a 1259053170
|
020 |
|
|
|a 9781624174759
|q ebook
|
020 |
|
|
|a 1624174752
|
020 |
|
|
|z 161209841X
|q hardcover : alk. paper
|
020 |
|
|
|z 9781612098418
|q hardcover : alk. paper
|
029 |
1 |
|
|a AU@
|b 000053297301
|
029 |
1 |
|
|a DEBBG
|b BV041049560
|
029 |
1 |
|
|a DEBBG
|b BV043961334
|
029 |
1 |
|
|a DEBBG
|b BV044089262
|
029 |
1 |
|
|a DEBSZ
|b 481299270
|
029 |
1 |
|
|a NZ1
|b 15347615
|
035 |
|
|
|a (OCoLC)994495531
|z (OCoLC)829713428
|z (OCoLC)961655039
|z (OCoLC)962649340
|z (OCoLC)965991988
|z (OCoLC)988475899
|z (OCoLC)992090558
|z (OCoLC)1037904267
|z (OCoLC)1038624979
|z (OCoLC)1045477798
|z (OCoLC)1055404289
|z (OCoLC)1058076375
|z (OCoLC)1066644404
|z (OCoLC)1081272570
|z (OCoLC)1153511527
|z (OCoLC)1259053170
|
050 |
0 |
0 |
|a RC695
|
060 |
1 |
0 |
|a WG 620
|
072 |
|
7 |
|a MED
|x 010000
|2 bisacsh
|
082 |
0 |
0 |
|a 616.1/43
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Varicose veins :
|b symptoms, causes, and treatments /
|c Andrea L. Nelson, editor.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers,
|c [2011]
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Public health in the 21st century
|
490 |
1 |
|
|a Neuroanatomy research at the leading edge
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
|
|
|a Description based on print version record.
|
546 |
|
|
|a English.
|
505 |
0 |
|
|a VARICOSE VEINS: SYMPTOMS, CAUSES AND TREATMENTS ; VARICOSE VEINS: SYMPTOMS, CAUSES AND TREATMENTS ; CONTENTS ; PREFACE ; VARICOSE VEINS ARE CAUSED BY SEGMENTAL FAILURES OF THE VASOREGULATORY ROLE OF THE VENOUS MICROCIRCULATION, MEDIATED BY PLASMA NOREPINEPHRINE ; ABSTRACT ; SECTION 1. ; Introduction ; SECTION 2. ; The Experimental Design ; Turbulence ; The A/V Module ; Cardiac A/V Modules ; Drainage of the A/V Module ; A/V Shunts ; The Structural and Functional Independence of Modules ; The Regulatory Function of the Adrenergic Plexus and the Microcirculation.
|
505 |
8 |
|
|a Evidence of the Dilator Effect of Microcirculatory NE In Vivo Factors That Determine and Affect Venous Tone ; The Role of the Vascular Microcirculation ; The Renal Capsular Microcirculation ; The Pharmacology of the Microcirculation ; SECTION 3. ; The Stenotic Constrictor Effect of Isoprenaline; THE VALVE AGGER ; The Role of the Agger in Reflux; The Venodilator Potency of Microcirculatory NE ; In Vivo Plasma NE Concentrations and Varicosities; Varicosities Caused by Orthograde Perfusion ; Arterial Dilitation Caused by Microcirculatory NE ; SECTION 4. ; Validation.
|
505 |
8 |
|
|a The Multiplication of Varicosities Therapeutic Options ; SECTION 5. ; The Bipolar Nature of the NE Stimulus; The Roles of Neuronal and Plasma NE in Smooith Muscle Contraction ; The Roles of NE in Smooth Muscle Contraction ; Contraction in the Microcirculation; The Role of the General Microcirculation ; CONCLUSION ; REFERENCES ; THE ROLE OF INFLAMMATION IN THE VARICOSE VEIN PATHOLOGY: NEW INSIGHTS ; ABSTRACT ; 1. INTRODUCTION ; 2. INFLAMMATION AND CHRONIC VENOUS DISEASE ; 2.1. Types and Distribution of Cells ; 2.1.1. Leukocytes ; 2.1.2. Endothelial Cells ; 2.1.3. Other Cells.
|
505 |
8 |
|
|a 2.2. Extracelular Matrix 2.3. Inflammatory Mediators ; 2.3.1. Adhesion Molecules ; 2.3.2. MMPs ; 2.3.3. Cytokines ; 2.3.4. Growth Factors ; 2.3.5. Hypoxia-Inducible Factors (HIF) ; 2.3.6. Oxidative Stress ; 2.3.7. Lipid Mediators ; 2.4. Mechanisms for Cell Activation and Inflammation ; 3. THERAPEUTICAL APPROACHES TO CVD ; 3.1. Current Therapies ; 3.1.2. Compressive Therapy ; 3.1.3. Surgical And Interventional Treatment ; 3.2. Pharmacological Therapy ; 3.2.1. Venoactive Drugs ; 3.2.1.1. Flavonoids and its Derivatives ; 3.2.1.2. Other Natural Venoactive Drugs ; 3.2.2. Non-Venoactive Agents.
|
505 |
8 |
|
|a 3.2.2.1. Prostaglandin E1 3.2.2.2. Prostacyclin Analogues ; 3.2.2.3. Pentoxifylline ; 3.2.2.4. Acetylsalicylic Acid (ASA) ; 3.2.2.5. Synthetic Peptide ; 3.2.3. Other Potential Pharmacological Agents ; CONCLUSION ; DECLARATION ; REFERENCES ; ASCENDING EVOLUTION OF VARICOSE VEINS: LITERATURE REVIEW AND RATIONALE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; PATHOPHYSIOLOGY OF VARICOSE VEINS AND "RETROGRADE THEORY" ; ASCENDING THEORY ; 1. Ascending Theory: Rationale and Theoretical Assumptions ; 2. Ascending Theory: Clinical Evidence ; A. Clinical Data on Patterns of Venous Varicosities.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Varicose veins.
|
650 |
|
2 |
|a Varicose Veins
|
650 |
|
6 |
|a Varices.
|
650 |
|
7 |
|a MEDICAL
|x Cardiology.
|2 bisacsh
|
650 |
|
7 |
|a Varicose veins.
|2 fast
|0 (OCoLC)fst01164449
|
700 |
1 |
|
|a Nelson, Andrea L.
|
776 |
0 |
8 |
|i Print version:
|t Varicose veins
|d New York : Nova Science Publishers, c2011.
|z 9781612098418 (hardcover : alk. paper)
|w (DLC) 2011004968
|
830 |
|
0 |
|a Public health in the 21st century series.
|
830 |
|
0 |
|a Neuroanatomy research at the leading edge.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535228
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3021554
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10683293
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 535228
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10251531
|
994 |
|
|
|a 92
|b IZTAP
|